Company intelligence / Profile preview

ACOBO

Seongnam-si, Gyeonggi-do, South Koreaacobo.co.kr ↗

Ownership: Private
Development stage: Other

Overview

Acobo is a South Korean biotechnology company specializing in the development of exosome-based therapeutics and regenerative medicine. The company utilizes its proprietary Exo-Platform to isolate high-purity exosomes and engineer them for targeted drug delivery and tissue repair. Acobo's pipeline focuses on high-need areas such as atopic dermatitis, alopecia, and oncology. By leveraging the natural signaling capabilities of exosomes, the company aims to provide next-generation treatments with improved safety and efficacy profiles compared to traditional biologics.

Therapeutic areas: OncologyDermatology
Modalities: Exosome-based therapyBiologic
Industry: Biotech

Beyond the preview

Go deeper on ACOBO.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on ACOBO.

Explore the full profile